Early Acute Kidney Injury in Allogeneic Hematopoietic Cell Transplantation: Incidence, Severity, and Associated Factors in a 634‐Recipient Cohort
European Journal of Haematology · 2026-10 · 117 (4) · 981-994
DOI: 10.1111/ejh.70227 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift European Journal of Haematology, online erschienen am 21.05.2026. Verfasst von Luiz Carlos da Costa-Junior und 10 weiteren Autor:innen. Beteiligte Einrichtung: Postgraduate Program in Medical Sciences, Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, Brazil. Hauptthemen laut MEDLINE: Acute Kidney Injury, Hematopoietic Stem Cell Transplantation, Transplantation Conditioning. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Fundação de Amparo à Pesquisa do Estado de São Paulo, Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro.
Abstract (Originalsprache)
Background
Acute kidney injury (AKI) is a frequent and clinically relevant complication in allogeneic hematopoietic cell transplantation (HCT) recipients, particularly during the early post‐HCT period. Although AKI has been extensively reported in long‐term follow‐up studies, data focusing on the initial hospitalization phase remain limited, despite its potential impact on subsequent clinical outcomes.
Objective
To evaluate the incidence, severity, and clinical and transplant‐related determinants of AKI during the first 3 weeks after allogeneic HCT.
Methods
We conducted a retrospective cohort study including 634 consecutive recipients undergoing allogeneic HCT between 2002 and 2023. AKI was defined according to KDIGO criteria and assessed from day +1 to day +21. Cumulative incidence was estimated, and associations were evaluated using Cox proportional hazards models. Pre‐AKI exposure to calcineurin inhibitors was analyzed.
Results
By day 21, AKI occurred in 346 patients (55%), and 27% of cases reached KDIGO stages 2–3. Median time to AKI was 12 days, with earlier onset among stage 3 events (median 5 days). In multivariable analysis, AST > 40 U/L was independently associated with an increased risk of any‐stage AKI (HR 1.58, 95% CI 1.17–2.12; p = 0.003), whereas albumin > 3.5 g/dL was protective (HR 0.56, 95% CI 0.44–0.71; p < 0.001). Severe AKI was associated with AST > 40 U/L (HR 1.93, 95% CI 1.08–3.44; p = 0.025) and year of transplantation, with higher risk observed in earlier categories (2002–2008: HR 3.68, 95% CI 1.75–7.72; p < 0.001), while higher albumin levels remained inversely associated (HR 0.42, 95% CI 0.26–0.70; p < 0.001). Higher pre‐AKI cyclosporine trough levels (HR 1.11, 95% CI 1.05–1.17; p < 0.001) and a greater proportion of supratherapeutic days (HR 1.06, 95% CI 1.02–1.10; p = 0.005) were also associated with AKI.
Conclusion
Early AKI in HCT recipients is strongly associated with baseline clinical vulnerability, hepatic dysfunction, and calcineurin inhibitor exposure. Elevated AST and lower albumin levels identify patients at increased risk, while higher cyclosporine exposure contributes to early renal injury. In contrast, transplant‐related characteristics show limited independent influence. These findings support early risk stratification, careful therapeutic monitoring, and individualized immunosuppression to reduce renal complications during the initial post‐HCT period.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Postgraduate Program in Medical Sciences, Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, Brazil.
- Bone Marrow Transplant Center, Instituto Nacional de Câncer (INCA), Rio de Janeiro, Brazil.
- Bone Marrow Transplant Program, Hospital Universitário Clementino Fraga Filho (HUCFF), Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil.
- Escola de Ciências da Saúde, Afya Universidade Unigranrio, Duque de Caxias, Brazil.
- Division of Nephrology, Hospital Universitário Clementino Fraga Filho (HUCFF), Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil.
- Faculdade de Ciências Médicas, Universidade Estadual de Campinas (Unicamp), Campinas, Brazil.
ORCID-Profile: Luiz Carlos da Costa-Junior, Maria Claudia Rodrigues Moreira, Paulo Caleb Júnior Lima Santos
Förderung
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
Zitieren
APA
da Costa-Junior, L. C., Tavares, R. C. B. D. S., Izu, M., Maradei, S. C., Moreira, M. C. R., Nogueira, M. C., Lerner, D., Bino, F. G., Moriel, P., de Souza Fernandez, T., & Santos, P. C. J. L. (2026). Early Acute Kidney Injury in Allogeneic Hematopoietic Cell Transplantation: Incidence, Severity, and Associated Factors in a 634‐Recipient Cohort. European Journal of Haematology, 117(4), 981-994. https://doi.org/10.1111/ejh.70227
Vancouver
da Costa-Junior LC, Tavares RCBDS, Izu M, Maradei SC, Moreira MCR, Nogueira MC, et al. Early Acute Kidney Injury in Allogeneic Hematopoietic Cell Transplantation: Incidence, Severity, and Associated Factors in a 634‐Recipient Cohort. European Journal of Haematology. 2026;117(4):981-994. doi:10.1111/ejh.70227
BibTeX
@article{daCostaJunior2026,
author = {da Costa-Junior, Luiz Carlos and Tavares, Rita de Cássia Barbosa da Silva and Izu, Marina and Maradei, Simone Cunha and Moreira, Maria Claudia Rodrigues and Nogueira, Marta Colares and Lerner, Décio and Bino, Fabrício Guimarães and Moriel, Patrícia and de Souza Fernandez, Teresa and Santos, Paulo Caleb Júnior Lima},
title = {Early Acute Kidney Injury in Allogeneic Hematopoietic Cell Transplantation: Incidence, Severity, and Associated Factors in a 634‐Recipient Cohort},
journal = {European Journal of Haematology},
year = {2026},
volume = {117},
number = {4},
pages = {981--994},
doi = {10.1111/ejh.70227}
}
EUVIMED